Skip links and keyboard navigation

Recall - Textured breast implants and tissue expanders

23 August 2019

The Therapeutic Goods Administration removed the Allergan BIOCELL textured breast implants and tissue expanders from the Australian market after a review found the devices have a small risk of causing Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).

All women with Allergan BIOCELL textured breast implants are advised to be aware of BIAALCL symptoms and to perform regular breast self-examinations. Women are advised to consult their doctor if symptoms develop, if any changes are noticed on self-examination, or if they have any concerns.

For information about the recall and risks of breast implants, you can visit the following web sites -

http://conditions.health.qld.gov.au/HealthCondition/condition/21/52/830/breast-implantassociated-anaplastic-large-ce

http://www.tga.gov.au/breast-implant-associated-cancer-or-bia-alcl

Last updated 23 August 2019
Last reviewed 23 August 2019

Other news

Have you updated your practice referral templates to Version 4.0?

Does your practice have the current version of The Refer Your Patient templates for Best Practice, Medical Director, Genie and ZedMed?

Is your practice CDA (Clinical Document Architecture) ready?

Queensland Health sends discharge summaries to practices by post, fax and electronically into the practice software.